首页 | 本学科首页   官方微博 | 高级检索  
     

易必生治疗慢性病毒性肝炎伴中重度黄疸疗效观察
引用本文:江堤,扬光,罗万蓉. 易必生治疗慢性病毒性肝炎伴中重度黄疸疗效观察[J]. 华西医学, 2008, 23(2): 285-286
作者姓名:江堤  扬光  罗万蓉
作者单位:德阳市医院传染科,四川德阳,618000
摘    要:目的:讨论易必生治疗慢性病毒性肝炎伴中重度黄疸的疗效。方法:160例患者分为两组,治疗组用易必生(多烯磷脂酰胆碱)465mg加入糖水静滴,对照组单用综合治疗。结果:治疗组症状、体征改善明显优于对照组(P<0.05),治疗组胆红素(TB)下降>50者及丙氨酸转氨酶(ALT)恢复正常例数均优于对照组(P<0.05),但血清白蛋白(A/G)比例的提高两组无显著差异(P>0.05),结论:易必生治疗慢性病毒性肝炎伴中重度黄胆有一定的疗效。

关 键 词:中重度黄疸  易必生
文章编号:1002-0179(2008)02-0285-02
修稿时间:2007-09-18

The Observation of the Effect of Curing Chronic Virus Hepatitis with Medium-deadly Jaundice Using the Medicine of Yi Bisheng
JIANG Di,YANG Guang,LUO Wan-rong. The Observation of the Effect of Curing Chronic Virus Hepatitis with Medium-deadly Jaundice Using the Medicine of Yi Bisheng[J]. West China Medical Journal, 2008, 23(2): 285-286
Authors:JIANG Di  YANG Guang  LUO Wan-rong
Abstract:Objective:Discuss the effect of curing chronic virus hepatitis with medium-deadly jaundice using the medicine of Yi Bisheng.Method:One hundred and sixty patients are divided into two groups,one is curing group with 465mg of Yi Bisheng mixing with sugar water,the other is contrasting group with comprehensive cure.Results:The improvement of symptom is prior obviously to the contrasting group(P<0.05).The patients with the quota of TB lowering half and the patients whose ALT is restored normal are both prior to the contrasting group(P<0.05).But the increase of A/G has no obvious difference between the two groups.Conclusion:Curing chronic virus hepatitis with medium-deadly jaundice using Yi Bisheng has effects in some degree.
Keywords:medium-deadly jauudice  Yi Bisheng
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号